New mesothelioma drug turns cancer’s own defenses against it

Scientists are testing a new experimental drug that fights aggressive mesothelioma cancer by disabling its antioxidant defenses. Early clinical trials show promising results, controlling disease progression in 67% of patients and offering hope for future cancer treatments.